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lesions absorption rate (12th mos: RR 1.26, 95% CI 1.09 to 1.46,
n=3; 18th mos: RR 1.18, 95%CI 1.07 to 1.30, n=6) and pulmonary
cavity closure rate by radiological examination (18th mos: RR
1.24, 95%CI 1.01 to 1.51; n=4), relapse rate (RR 0.28, 95%CI 0.16
to 0.50, n=4), and abnormal liver function (RR 0.56, 95% CI 0.46
to 0.69, n=14).
Conclusion: CHM as an adjuvant to anti-TB chemotherapy
may have beneﬁcial effect for MDR-TB in terms of bacteriolog-
ical and radiological outcomes, and is safe. However, due to
poor methodology of the included trials, a conﬁrmative con-
clusion needs to be supported through further robust clinical
trial.
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Purpose: The Chinese Quality of Life Instrument (ChQOL)
is the ﬁrst patients reported outcome (PRO) established bas-
ing on the health concept of Traditional Chinese Medicine
(TCM) among most instruments based on Western culture. It
has been culturally adapted in China, Australia, France and
Hong Kong with satisfactory psychometric properties. ChQOL
consists of 50 items in 13 facets which are grouped in three
domains: (1) physical form, (2) vitality and spirit and (3) emo-
tion. However, the ChQOL was regarded as lengthy, which
hinders its application as an outcome measure. Therefore, we
aim at developing a brief version ranging from 13-26 items of
the ChQOL to ease administration and facilitate wider appli-
cation.
Methods: Two short forms of ChOQL (26-item or 13-item
with 1-2 items per facet) were developed by a secondary anal-
ysis (regression analysis and classical test theory), based on
empirical data of 1,410 of healthy to a wide range of diseases
severity subjects. These two short forms of ChQOL were val-
idated by (1) 20 registered Chinese Medicine practitioners on
the content and (2) a sample of 1,056 subjects, covering a range
of health status (fromhealthy to severely ill) inHongKong. The
brief versions of ChQOL were examined on the structure ﬁt-
ness, construct validity, equivalency when compared with the
full version.
Results: Complied with ISOPOR, the psychometric proper-
ties of two short forms were investigated and compared with
the full version.
Conclusion: The ﬁrst PRO, based on the health concept of
TCM,ChQOLwill be shortened to facilitate awider application.
The item reduction process is essential to advance of quality
of life study, like SF-36, WHOQOL. The shortening will also
improve completion rate with elderly who have low vision or
physical disability or serious illness. With easy interpretation,
ChQOL could be more readily incorporated into routine care,
or used in larger population studies.
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Purpose: This project aimed to select promising herbs for
treating psoriasis vulgaris based on the results of clinical,
experimental and in-silico studies and to explore the possible
actions of multiple compounds on multiple targets relevant to
this disease.
Methods: Meta-analysis of clinical trials combined with
reviews of experimental studies were used to short-list herbs
that showed promise of efﬁcacy for psoriasis vulgaris as well
as have anti-proliferative and/or anti-inﬂammatory actions.
Databases were used to identify the compounds contained in
the herbs, the protein targets of these compounds and the
metabolic pathways in which the proteins are involved.
Results: The clinical and experimental studies identiﬁed
12 herbs that showed evidence of efﬁcacy in clinical trials and
evidence of activity in experimental studies. These herbs con-
tained 60+ compounds which have been reported to act on
350+ proteins. Of these, multiple proteins were involved in
apoptosis, inﬂammation and angiogenesis. Proteins of known
relevance to psoriasis included Tumor Necrosis Factor and
Cyclooxygenasewhichwere down-regulated bymultiple com-
pounds in the herbs. Proteins relevant to apoptosis that were
regulated by multiple compounds included Apoptosis regula-
tor Bcl-2, Apoptosis regulator BAX, Caspase-3 and Caspase-9.
Multiple compounds were identiﬁed as inhibiting angiogene-
sis via Vascular Endothelial Growth Factor. Within some single
herbs, multiple compounds appeared to be acting on multiple
proteins within a pathway suggesting that its clinical actions
may be based on multi-compound multi-target effects.
Conclusion: This approach links the results of systematic
reviews and meta-analyses of clinical studies to the results
of experimental research by focusing on how compounds
contained in herbs could be acting on multiple proteins to
affect the inﬂammatory and proliferative processes involved
in psoriasis. The results indicate that multiple herbs contain
compounds that regulate known psoriasis targets as well as
other proteins that may be involved in the development and
or maintenance of psoriasis lesions.
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